V260

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for V260, covering 2009-09-23 to 2016-04-04. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy, Safety, and Immunogenicity of V260 in Healthy Chinese Infants (V260-024) [Phase 3]